Nanoantidote for repression of acidosis pH promoting COVID-19 infection
© 2022 The Authors. VIEW published by Shanghai Fuji Technology Consulting Co., Ltd, authorized by Professional Community of Experimental Medicine, National Association of Health Industry and Enterprise Management (PCEM) and John Wiley & Sons Australia, Ltd.
Détails bibliographiques
| Publié dans: | View (Beijing, China). - 2020. - 3(2022), 4 vom: 05. Juli, Seite 20220004
|
|---|
| Auteur principal: |
Liu, Qidong
(Auteur) |
|---|
| Autres auteurs: |
Ruan, Huitong,
Sheng, Zhihao,
Sun, Xiaoru,
Li, Siguang,
Cui, Wenguo,
Li, Cheng |
|---|
| Format: | Article en ligne
|
|---|
| Langue: | English |
|---|
| Publié: |
2022
|
|---|
| Accès à la collection: | View (Beijing, China)
|
|---|
| Sujets: | Journal Article
ACE2
COVID‐19
F‐actin
SARS‐CoV‐2
acidosis
antacid
nanoantidote |
|---|